MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

Clinical trial NCT01770353 · COMPLETED

Trial details

NCT number: NCT01770353
Sponsor: Ipsen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors ER/PR Positive Breast Cancer Triple Negative Breast Cancer Metastatic Breast Cancer With Active Brain Metastasis

Start date: 2012-11-01
Primary completion: 2018-10-02
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.